Menu

First Wave BioPharma, Inc. FWBI

Full chart Compare
Set alert

Price alert · FWBI

All alert types
2.96 +2.96

Day range unavailable

52-week range unavailable

Analyst view

Consensus: buy

Buy
Price target (mean) 36.00
Ratings (-1m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • 1 month ago 1
  • 2 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

FWBI analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.32-0.32 – -0.32-37.80+99.2%00.0%1
Next quarter-0.37-0.37 – -0.37-9.20+96.0%00.0%1
Current year-1.80-1.80 – -1.80-47.88+96.2%00.0%1
Next year-1.55-1.55 – -1.55-1.80+13.9%00.0%1

Upgrades and downgrades

The latest rating changes

FWBI analyst upgrades and downgrades
DateFirmActionFromTo
Sep 18, 2023Roth MKMReiteratedBuyBuy
Jul 13, 2023HC Wainwright & Co.DowngradeBuyNeutral
Jun 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 25, 2023HC Wainwright & Co.Reiterated—Buy
Apr 4, 2023HC Wainwright & Co.Maintained—Buy
Mar 8, 2023HC Wainwright & Co.Reiterated—Buy
Feb 2, 2023HC Wainwright & Co.Reiterated—Buy
Jan 30, 2023HC Wainwright & Co.Reiterated—Buy
Jan 25, 2023HC Wainwright & Co.Reiterated—Buy